The miR-34a is a direct transcriptional target of tumor-suppressor gene p53 and miR-34a expression is commonly regarded as contributing to tumorigenesis by attenuating p53-dependent apoptosis in NSCLC patients [8]. The gene discussed is TP53; the disease is neoplasm.